Title: Method and Medicament for Inhibiting the Expression of a Given Gene
Patent Number: 8,114,851
Filed: Oct. 31, 2007
Lead Inventor: Roland Kreutzer, Alnylam Pharmaceuticals
IP Update: Recent Patents, Patent Applications Awarded to Alnylam; Regulus; Sanofi-Aventis; and More
Premium
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.